Flibanserin for hypoactive sexual desire disorder in premenopausal women

JAAPA : Official Journal of the American Academy of Physician Assistants
Jennifer N Clements, Brittany Thompson

Abstract

Flibanserin is a mixed 5-HT1A agonist and 5-HT2A antagonist for treatment of premenopausal women with hypoactive sexual desire disorder. It is the first FDA-approved treatment for this disorder and can improve the number of satisfying sexual events. The drug has been associated with hypotension and syncope.

References

Sep 25, 2009·Archives of Sexual Behavior·Lori A Brotto
Jan 14, 2012·The Journal of Sexual Medicine·John ThorpUNKNOWN DAISY trial investigators
Jan 18, 2012·The Journal of Sexual Medicine·Leonard R DerogatisUNKNOWN VIOLET Trial Investigators
May 16, 2013·The Journal of Sexual Medicine·Molly KatzUNKNOWN BEGONIA trial investigators
Nov 26, 2015·Indian Journal of Psychiatry·T S Sathyanarayana Rao, Chittaranjan Andrade
Dec 10, 2015·The New England Journal of Medicine·Hylton V JoffeJulie Beitz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.